#
#

Scientific Programme

Wednesday, May 31 | Thursday, June 1 | Friday, June 2 | Saturday, June 3

 

GEST Europe 2017 Full Programme / Pocket Guide (PDF download 2.23 MB)

GEST Europe 2017 Timetable at a glance (PDF download 32 KB)

GEST Europe 2017 Floor Plans (PDF download 82 KB)

 

 

Wednesday, May 31

  08:00-09:45  
  Plenary Session  
101 Coils and Plugs Main
  Moderators: A.-M. Belli (London/UK), J. Golzarian (Minneapolis, MN/US) Auditorium
101.1 Catheter choice for delivery of plugs and coils
O.M. van Delden (Amsterdam/NL)
 
101.2 Techniques for coil deployment
G. Maleux (Leuven/BE)
 
101.3 When to stop: endpoints for mechanical embolisation
K. Osuga (Osaka/JP)
 
101.4 Technical differences between coils: density, fibres and hydrogel
D. Vorwerk (Ingolstadt/DE)
 
101.5 Plugs and microplugs: update
M.A. Ruffino (Turin/IT)
 
101.6 Coils, plugs or both: when and why
B. Arslan (Chicago, IL/US)
 
101.7 Complications using coils and plugs: how to avoid and how to solve!
O.M. van Delden (Amsterdam/NL)
 
101.8 Debate - Detachable coils: pro
J.-P. Pelage (Caen/FR)
 
101.9 Debate - Detachable coils: con
M.S. Johnson (Indianapolis, IN/US)
 
101.10 Advanced clinical cases
J.F. Benenati (Miami, FL/US)
 
101.11 Advanced clinical cases
D. Vorwerk (Ingolstadt/DE)
 
  Discussion  
     
 
  10:15-12:00  
  Parallel Session  
201 Trauma Sala
  Moderators: B.S. Funaki (Chicago, IL/US), P.L. Pereira (Heilbronn/DE) Verde
201.1 Management algorithms for trauma
M.D. Darcy (St. Louis, MO/US)
 
201.2 Splenic embolisation: proximal vs. distal embolisation
R. Uberoi (Oxford/UK)
 
201.3 Hepatic trauma embolisation: how to minimise complications
M. Cariati (Milan/IT)
 
201.4 Blunt and penetrating renal trauma: when and how to embolise
P.P. Goffette (Brussels/BE)
 
201.5 Embolisation of pelvic trauma: technique and outcomes
M.S. Hamady (London/UK)
 
201.6 Endovascular management for iatrogenic non-visceral injuries
R. Uberoi (Oxford/UK)
 
201.7 Endovascular management of extremity trauma
M. Cariati (Milan/IT)
 
201.8 Endovascular management of aortic trauma
H. Rousseau (Toulouse/FR)
 
201.9 Endovascular management of head and neck trauma
L. Defreyne (Ghent/BE)
 
201.10 Debate - Empiric embolisation for pelvic trauma: safe and indicated
O.M. van Delden (Amsterdam/NL)
 
201.11 Debate - Empiric embolisation for pelvic trauma: increases complications
W.E. Saad (Ann Arbor, MI/US)
 
  Discussion  
     
 
  10:15-12:00  
  Parallel Session  
202 HCC Main
  Moderators: Y. Arai (Tokyo/JP), C.E. Ray, Jr. (Chicago, IL/US) Auditorium
202.1 Patient assessment before IR treatment
R. Lencioni (Miami, FL/US)
 
202.2 Basics of radioembolisation dosimetry
T.F. Jakobs (Munich/DE)
 
202.3 Results of conventional TACE
G. Mauri (San Donato Milanese/IT)
 
202.4 Results of drug-eluting TACE
K. Malagari (Athens/GR)
 
202.5 HCC with portal vein occlusion TARE or TACE
R.J. Lewandowski (Chicago, IL/US)
 
202.6 Radiation segmentectomy and/or lobectomy
R.J. Lewandowski (Chicago, IL/US)
 
202.7 Matching therapy to patient
M. Grosso (Cuneo/IT)
 
202.8 Downstaging and bridging to transplantation
C.E. Ray, Jr. (Chicago, IL/US)
 
202.9 Debate - Is there a role for embolisation pre TARE: pro
K. Ahrar (Houston, TX/US)
 
202.10 Debate - Is there a role for embolisation pre TARE: con
P.L. Pereira (Heilbronn/DE)
 
202.11 Alternative chemotherapeutic agents for TACE
Y. Arai (Tokyo/JP)
 
202.12 Anti-reflux or flow arrest for TACE
S. Miyayama (Fukui/JP)
 
  Discussion  
     
 
  14:00-15:00  
  Hands-on Workshop  
HoW 1 Coils and plugs HoW Room
     
 
  14:15-15:45  
  Parallel Session  
401 Imaging Main
  Moderators: N. McEniff (Dublin/IE), O. Pellerin (Paris/FR) Auditorium
401.1 New guidance tool for liver embolisation
B.C. Meyer (Hannover/DE)
 
401.2 Practical aspects of live image guidance during embolisation procedures
H. Kobeiter (Créteil/FR)
 
401.3 CBCT in liver embolisation: optimising parameters
D.Y. Sze (Stanford, CA/US)
 
401.4 Use of advanced planning & guidance software for complex liver tumour embolisation
R. Lencioni (Miami, FL/US)
 
401.5 Role of US in the angio suite for defining the right target for TACE/TAE
F. Orsi (Milan/IT)
 
401.6 Fusion imaging: how to use it to optimise embolisation
B.C. Meyer (Hannover/DE)
 
401.7 Can CBCT flow and perfusion provide endpoints for tumour embolisation
O. Pellerin (Paris/FR)
 
401.8 CBCT: how much is the radiation load to the patient
H. Kobeiter (Créteil/FR)
 
  Discussion  
     
 
  14:15-15:15  
  Clinical Case-Based Discussion  
402 Radioembolisation dose calculation, mapping and follow-up Sala
    Verde
402.1 G. Maleux  (Leuven/BE)  
402.2 M. Grosso (Cuneo/IT)  
     
 
  15:15-16:15  
  Clinical Case-Based Discussion  
403 Embolisation of bronchial and pulmonary artery Sala
    Verde
403.1 withdrawn  
403.2 J. Pollak (New Haven, CT/US)  
     
 
  15:30-16:30  
  Hands-on Workshop  
HoW 2 Coils and plugs HoW Room
     
 
  16:15-17:45  
  Parallel Session  
501 GU embolisation Main
  Moderators: L. Machan (Vancouver/CA), V. Vidal (Marseille/FR) Auditorium
501.1 Varicocele embolisation: technique
P. Haage (Wuppertal/DE)
 
501.2 Varicocele embolisation and fertility: results
L. Machan (Vancouver/CA)
 
501.3 Embolisation of angiomyolipomas: technique and outcomes
L.B. Lönn (Copenhagen/DK)
 
501.4 Embolisation in polycystic kidney disease for volume reduction
F. Petitpierre (Bordeaux/FR)
 
501.5 Embolisation in non-functioning renal allografts in patients with graft intolerance syndrome (GIS)
F. Petitpierre (Bordeaux/FR)
 
501.6 Embolisation in priapism
N. McEniff (Dublin/IE)
 
501.7 Embolotherapy of haematuria of non-renal origin
L.B. Lönn (Copenhagen/DK)
 
501.8 PAE for prostate cancer: early experience
T. Bilhim (Lisbon/PT)
 
501.9 Non-vascular embolisation for urological problems
Y. Arai (Tokyo/JP)
 
  Discussion  
     
 
  16:15-17:15  
  Clinical Case-Based Discussion  
502 Management of complex HCC Sala
    Verde
502.1 K. Malagari (Athens/GR)  
502.2 F. Orsi (Milan/IT)  
     
 
  17:00-18:00  
  Hands-on Workshop  
HoW 3 Coils and plugs HoW Room

TOP
 

Thursday, June 1

  08:00-09:45  
  Parallel Session  
701 Liquid embolic agents Main
  Moderators: I. McCafferty (Birmingham/UK), D.Y. Sze (Stanford, CA/US) Auditorium
701.1 Principles and comparison of liquid agents
S. Comelli (Turin/IT)
 
701.2 Glue: preparations and formulations
Y. Arai (Tokyo/JP)
 
701.3 Onyx vs. Squid vs. Phil
V. Vidal (Marseille/FR)
 
701.4 Sclerosing agents and foam: agent selection and technical tips
M. Grosso (Cuneo/IT)
 
701.5 Tips and tricks for non-sclerosing liquid agents
L. Defreyne (Ghent/BE)
 
701.6 Tips and tricks for sclerosing liquid agents/When to stop: endpoints and how to avoid complications
D.Y. Sze (Stanford, CA/US)
 
701.7 Ethiodised oils (Lipiodol): more than an embolic transporter
S. Miyayama (Fukui/JP)
 
701.8 cancelled  
701.9 Debate - If I could only have one, I would use glue
V. Vidal (Marseille/FR)
 
701.10 Debate - If I could only have one, I would use EVOH-based agents
L. Defreyne (Ghent/BE)
 
701.11 Advanced clinical cases
Y. Arai (Tokyo/JP)
 
701.12 Advanced clinical cases
D. Savio (Turin/IT)
 
  Discussion  
     
  08:00-09:45  
  Parallel Session  
702 Fibroid embolisation Sala
  Moderators: S.J. Park (Incheon/KR), J.B. Spies (Washington, DC/US) Verde
702.1 New developments in the medical management of fibroids
P.N.M. Lohle (Tilburg/NL)
 
702.2 Embolic agents for UAE: systematic review
R. Das (London/UK)
 
702.3 Embolisation specific endpoints for different agents
J.B. Spies (Washington, DC/US)
 
702.4 Embolisation of non-uterine collaterals
P.N.M. Lohle (Tilburg/NL)
 
702.5 Guidelines of fibroid embolisation: international perspective
M. Sone (Tokyo/JP)
 
702.6 UFE and fertility update
J.-P. Pelage (Caen/FR)
 
702.7 Clinical role of IR in UFE
A.-M. Belli (London/UK)
 
702.8 Peri-procedural pain reduction: blocks, epidurals, sedation and alternative medicine
C.A. Binkert (Winterthur/CH)
 
702.9 Complications: how to minimise and manage
T.J. Kroencke (Augsburg/DE)
 
702.10 Advanced clinical cases
F. Orsi (Milan/IT)
 
702.11 Advanced clinical cases
R. Das (London/UK)
 
  Discussion  
     
  10:15-12:00  
  Parallel Session  
801 Vascular and lymphatic malformations Sala
  Moderators: Y.-S. Do (Seoul/KR), J.A. Reekers (Amsterdam/NL) Verde
801.1 Vascular malformations: diagnosis and classification
W.A. Wohlgemuth (Regensburg/DE)
 
801.2 Which agents to use in malformations: low flow
P. Rowlands (Liverpool/UK)
 
801.3 Sclerotherapy technique, outcome and complications: low flow
M.-F. Giroux (Montreal/CA)
 
801.4 Which agents to use in malformations: high flow
J.A. Reekers (Amsterdam/NL)
 
801.5 Technique, outcome and complications: high flow
P. Rowlands (Liverpool/UK)
 
801.6 AVMs: embolising the arterialised veins
Y.-S. Do (Seoul/KR)
 
801.7 Advances in the use of dilute alcohol in AVMs
Y.-S. Do (Seoul/KR)
 
801.8 Management of renal AVMs
M.-F. Giroux (Montreal/CA)
 
801.9 Clinical and imaging follow-up after treatment
P. Haage (Wuppertal/DE)
 
801.10 Debate - High flow AVMs should be treated from a venous approach: pro
I. McCafferty (Birmingham/UK)
 
801.11 Debate - High flow AVMs should be treated from a venous approach: con
J.A. Reekers (Amsterdam/NL)
 
801.12 Advanced clinical cases
W.E. Saad (Ann Arbor, MI/US)
 
801.13 Advanced clinical cases
P. Rowlands (Liverpool/UK)
 
  Discussion  
     
  10:15-12:00  
  Parallel Session  
802 GI haemorrhage Main
  Moderators: C.A. Binkert (Winterthur/CH), R. Uberoi (Oxford/UK) Auditorium
802.1 Management algorithms for upper and lower GI haemorrhage
R. Uberoi (Oxford/UK)
 
802.2 Optimisation of angiographic technique and provocative manoeuvres
B.S. Funaki (Chicago, IL/US)
 
802.3 Safety and efficacy of embolisation for upper GI haemorrhage
P.P. Goffette (Brussels/BE)
 
802.4 Embolisation technique: how distal
G. Carrafiello (Milan/IT)
 
802.5 Safety and efficacy of embolisation for lower GI haemorrhage
R.C. Gaba (Chicago, IL/US)
 
802.6 Is there a role for empiric embolisation in the upper and lower GI tract?
N. McEniff (Dublin/IE)
 
802.7 Embolisation and stent grafts for post GI surgery bleeding
M.R. Sapoval (Paris/FR)
 
802.8 Technique and results of embolisation in haemorrhoids
V. Vidal (Marseille/FR)
 
802.9 Debate - Is there a role for liquid embolic agents: pro
L. Defreyne (Ghent/BE)
 
802.10 Debate - Is there a role for liquid embolic agents: con
B.S. Funaki (Chicago, IL/US)
 
  Discussion  
     
  14:00-15:00  
  Hands-on Workshop  
HoW 4 Liquid embolics HoW Room
     
  14:15-15:45  
  Parallel Session  
1001 Chest Main
  Moderators: P. Haage (Wuppertal/DE), J. Pollak (New Haven, CT/US) Auditorium
1001.1 Clinical and imaging workup for haemoptysis
G. Carrafiello (Milan/IT)
 
1001.2 Arterial anatomy and variants for haemoptysis
J. Pollak (New Haven, CT/US)
 
1001.3 Bronchial artery embolisation: long-term outcome and management of recurrence
R. Niola (Naples/IT)
 
1001.4 Bronchial artery embolisation: how to avoid complications
M.-F. Carette (Paris/FR)
 
1001.5 Debate - Liquids should replace particles in bronchial artery embolisation: pro
Z.J. Haskal (Charlottesville, VA/US)
 
1001.6 Debate - Liquids should replace particles in bronchial artery embolisation: con
T. Tanaka (Kashihara/JP)
 
1001.7 Pulmonary AVM: choice of materials and technical tips
J. Pollak (New Haven, CT/US)
 
1001.8 Endovascular management of pulmonary artery pseudoaneurysms
M.-F. Carette (Paris/FR)
 
1001.9 Intranodal lymphangiography and thoracic duct embolisation: technical TIPS
R.C. Gaba (Chicago, IL/US)
 
1001.10 Results of thoracic duct embolisation
R.C. Gaba (Chicago, IL/US)
 
  Discussion  
     
  14:15-15:15  
  Clinical Case-Based Discussion  
1002 Management of complex visceral aneurysms Sala
    Verde
1002.1 M. Szczerbo-Trojanowska (Lublin/PL)  
1002.2 M.S. Hamady (London/UK)  
     
  15:15-16:15  
  Clinical Case-Based Discussion  
1003 Varicoceles and pelvic congestion Sala
    Verde
1003.1 T. Jargiełło (Lublin/PL)  
1003.2 L. Machan (Vancouver/CA)  
     
  15:30-16:30  
  Hands-on Workshop  
HoW 5 Liquid embolics HoW Room
     
  16:15-17:45  
  Parallel Session  
1101 Abdominal embolisation Main
  Moderators: K. Ahrar (Houston, TX/US), K.A. Hausegger (Klagenfurt/AT) Auditorium
1101.1 Embolisation/ablation of benign liver lesions
K. Ahrar (Houston, TX/US)
 
1101.2 Embolisation for hypersplenism and thrombocytopaenia
M. Szczerbo-Trojanowska (Lublin/PL)
 
1101.3 Gastric artery embolisation: update of results and future directions
A. Arepally (Atlanta, GA/US)
 
1101.4 Transarterial therapy for pancreatic cancer
T. Tanaka (Kashihara/JP)
 
1101.5 Bleeding post-pancreatic transplant
J.F. Angle (Charlottesville, VA/US)
 
1101.6 Durable means to occlude the bile duct
E. Brountzos (Athens/GR)
 
1101.7 Embolisation for retroperitoneal and spontaneous abdominal wall haemorrhage
A. Krajina (Hradec Králové/CZ)
 
1101.8 Interventional management of haemobilia
K.A. Hausegger (Klagenfurt/AT)
 
1101.9 Management of GI fistulae
Z.J. Haskal (Charlottesville, VA/US)
 
  Discussion  
     
  16:15-17:15  
  Clinical Case-Based Discussion  
1102 Management of complex AVM Sala
    Verde
1102.1 I. McCafferty (Birmingham/UK)  
1102.2 W.A. Wohlgemuth (Regensburg/DE)  
     
  17:00-18:00  
  Hands-on Workshop  
HoW 6 Liquid embolics HoW Room

TOP

Friday, June 2

  08:00-09:45  
  Parallel Session  
1301 Particles and gelfoam Main
  Moderators: H.T. Abada (Abu Dhabi/AE), K. Osuga (Suita, Osaka/JP) Auditorium
1301.1 Particles and gelfoam: indications and choice of agents
D. Vorwerk (Ingolstadt/DE)
 
1301.2 Microparticles: what do we need to know
K. Osuga (Osaka/JP)
 
1301.3 When to stop: endpoints for particulate embolisation
R. Niola (Naples/IT)
 
1301.4 5 top tips and tricks using gelfoam
M. Sone (Tokyo/JP)
 
1301.5 5 top tips and tricks using particles
J.B. Spies (Washington, DC/US)
 
1301.6 Drug-eluting particles: characteristics
K. Malagari (Athens/GR)
 
1301.7 Complications using particles and gelfoam: how to avoid and how to solve!
H.T. Abada (Abu Dhabi/AE)
 
1301.8 Particles for embolisation: new development and future
J. Golzarian (Minneapolis, MN/US)
 
1301.9 Debate - Resorbable particles will replace non-resorbable particles: pro
A. Arepally (Atlanta, GA/US)
 
1301.10 Debate - Resorbable particles will replace non-resorbable particles: con
T.J. Kroencke (Augsburg/DE)
 
1301.11 Advanced clinical cases
K. Osuga (Suita, Osaka/JP)
 
1301.12 Advanced clinical cases
H. Kobeiter (Créteil/FR)
 
  Discussion  
     
  08:00-09:45  
  Parallel Session  
1302 Portal hypertension and portal venous embolisation Sala
  Moderators: Z.J. Haskal (Charlottesville, VA/US), G. Maleux (Leuven/BE) Verde
1302.1 Indications for RTO and/or TIPS
G. Maleux (Leuven/BE)
 
1302.2 Classic BRTO: anatomy and results
B. Arslan (Chicago, IL/US)
 
1302.3 PARTO: technique and results
D.I. Gwon (Seoul/KR)
 
1302.4 BRTO variants: ATOs and ARTOs
H. Kiyosue (Yufu/JP)
 
1302.5 Treatment of ectopic varices
R.C. Gaba (Chicago, IL/US)
 
1302.6 Transsplenic approaches to variceal embolisation
W.E. Saad (Ann Arbor, MI/US)
 
1302.7 Debate - Embolisation of portal venous varices during TIPS: pro
A. Krajina (Hradec Králové/CZ)
 
1302.8 Debate - Embolisation of portal venous varices during TIPS: con
H. Rousseau (Toulouse/FR)
 
1302.9 Splenic artery embolisation in patients with portal hypertension
S. Bhatia (Davie, FL/US)
 
1302.10 Principles and indications for portal venous embolisation
E. Brountzos (Athens/GR)
 
1302.11 Transarterial radioembolisation as an alternative to portal vein embolisation
R.J. Lewandowski (Chicago, IL/US)
 
1302.12 Advanced clinical cases
A.M. Ierardi (Varese/IT)
 
1302.13 Advanced clinical cases
D.I. Gwon (Seoul/KR)
 
  Discussion  
     
  10:15-12:00  
  Parallel Session  
1401 Prostate artery embolisation Main
  Moderators: F.C. Carnevale (São Paulo/BR), M.R. Sapoval (Paris/FR) Auditorium
1401.1 Current medical and surgical therapy: advantages and disadvantages
R. Das (London/UK)
 
1401.2 Patient evaluation and workup
N. Hacking (Southampton/UK)
 
1401.3 Prostate artery anatomy
T. Bilhim (Lisbon/PT)
 
1401.4 Step-by-step guide through PAE
F.C. Carnevale (São Paulo/BR)
 
1401.5 Optimising CBCT during PAE
M.R. Sapoval (Paris/FR)
 
1401.6 Selection of embolic agents for PAE
J. Golzarian (Minneapolis, MN/US)
 
1401.7 Clinical management and complications after PAE
N. Hacking (Southampton/UK)
 
1401.8 Debate - PAE is ready for wide-spread clinical adoption: pro
T. Bilhim (Lisbon/PT)
 
1401.9 Debate - PAE is ready for wide-spread clinical adoption: con
J.B. Spies (Washington, DC/US)
 
1401.10 Meta-analysis and systematic review of results of PAE
Z.J. Haskal (Charlottesville, VA/US)
 
1401.11 PAE - future directions
M.R. Sapoval (Paris/FR)
 
  Discussion  
     
  10:15-12:00  
  Parallel Session  
1402 Endoleaks Sala
  Moderators: J.F. Angle (Charlottesville, VA/US), M. Hamady (London/UK) Verde
1402.1 Definitions, frequency and natural history of endoleaks
J.F. Benenati (Miami, FL/US)
 
1402.2 Is there a role for prophylactic embolisation to prevent endoleaks?
M.D. Dake (Stanford, CA/US)
 
1402.3 Cone-beam CT for direct sac embolisation
O. Pellerin (Paris/FR)
 
1402.4 Embolisation techniques for type 1
R.A. Morgan (London/UK)
 
1402.5 Embolisation techniques for type 2
A. Chavan (Oldenburg/DE)
 
1402.6 Transcaval approach: a valid technique for type 2?
J.F. Angle (Charlottesville, VA/US)
 
1402.7 Embolisation in TEVAR
M.D. Dake (Stanford, CA/US)
 
1402.8 Imaging follow-up after embolisation
R. Iezzi (Rome/IT)
 
1402.9 Complications and outcomes
A. Chavan (Oldenburg/DE)
 
1402.10 Advanced clinical cases
R.A. Morgan (London/UK)
 
1402.11 Advanced clinical cases
R. Iezzi (Rome/IT)
 
  Discussion  
     
  14:00-15:00  
  Hands-on Workshop  
HoW 7 Particles and gelfoam HoW Room
     
  14:15-15:45  
  Parallel Session  
1601 Visceral aneurysms Main
  Moderators: J.F. Benenati (Miami, FL/US), R.A. Morgan (London/UK) Auditorium
1601.1 Epidemiology and treatment indications
K.A. Hausegger (Klagenfurt/AT)
 
1601.2 Hepatic and splenic artery aneurysms: embolisation techniques
J. Golzarian (Minneapolis, MN/US)
 
1601.3 Hepatic and splenic artery aneurysms: outcomes and complications
A.M. Ierardi (Varese/IT)
 
1601.4 Renal artery aneurysms: technique and outcomes
M. Szczerbo-Trojanowska (Lublin/PL)
 
1601.5 Management of pseudoaneurysm secondary to pancreatitis
M.-F. Giroux (Montreal/CA)
 
1601.6 Coeliac and SMA aneurysm: technique and outcomes
M.S. Hamady (London/UK)
 
1601.7 Imaging follow-up
R.A. Morgan (London/UK)
 
1601.8 Debate - Keeping the parent artery open: pro
A.M. Ierardi (Varese/IT)
 
1601.9 Debate - Keeping the parent artery open: con
J.F. Benenati (Miami, FL/US)
 
  Discussion  
     
  14:15-15:15  
  Clinical Case-Based Discussion  
1602 Complex UFE Sala
    Verde
1602.1 M. Sone (Tokyo/JP)  
1602.2 T. Bilhim (Lisbon/PT)  
     
  15:15-16:15  
  Clinical Case-Based Discussion  
1603 Prostate artery anatomy Sala
    Verde
1603.1 S. Bhatia (Davie, FL/US)  
1603.2 F.C. Carnevale (São Paulo/BR)  
     
  15:30-16:30  
  Hands-on Workshop  
HoW 8 Particles and gelfoam HoW Room
     
  16:15-17:45  
  Parallel Session  
1701 Women's health Main
  Moderators: R. Niola (Naples/IT), J.-P. Pelage (Caen/FR) Auditorium
1701.1 IR techniques in the management of morbidly adherent placenta
L.B. Lönn (Copenhagen/DK)
 
1701.2 Debate - Prophylactic embolisation before delivery: pro
F. Giurazza (Rome/IT)
 
1701.3 Debate - Prophylactic embolisation before delivery: con
A.-M. Belli (London/UK)
 
1701.4 PPH: when and how
J.-P. Pelage (Caen/FR)
 
1701.5 Complications of embolisation for PPH
T.J. Kroencke (Augsburg/DE)
 
1701.6 Embolisation of uterine AVMs
F. Giurazza (Rome/IT)
 
1701.7 Embolisation technique and results for adenomyosis
N. Hacking (Southampton/UK)
 
1701.8 Embolisation technique in pelvic congestion syndrome
T. Jargiełło (Lublin/PL)
 
1701.9 Management of perineal varicosities
A. Lopez (Guildford/UK)
 
  Discussion  
     
  16:15-17:15  
  Clinical Case-Based Discussion  
1702 Solid organ trauma Sala
1702.1 H.T. Abada (Abu Dhabi/AE)  
1702.2 J.F. Angle (Charlottesville, VA/US)  
 

TOP  

Saturday, June 3

1901 Morbidity and Mortality  
  M.R. Sapoval (Paris/FR), F. Fanelli (Rome/IT), R. Uberoi (Oxford/UK)  
1901.1 M.D. Darcy (St. Louis, MO/US)  
1901.2 T. de Baère (Villejuif/FR)  
1901.3 L. Defreyne (Ghent/BE)  
1901.4 O.M. van Delden (Amsterdam/NL)  
1901.5 G. Maleux (Leuven/BE)  
1901.6 R. Uberoi (Oxford/UK)  
1901.7 Y. Arai (Tokyo/JP)  
1901.8 J. Golzarian (Minneapolis, MN/US)  
     
  10:15-12:00  
  Parallel Session  
2001 Embolisation of liver metastatic cancer and cholangiocarcinoma Sala
  Moderators: A. Denys (Lausanne/CH), R. Lencioni (Miami, FL/US) Verde
2001.1 When should embolisation be considered for colorectal liver mets?
A. Denys (Lausanne/CH)
 
2001.2 Irinotecan eluting particles for colorectal metastases: is there a role?
T.F. Jakobs (Munich/DE)
 
2001.3 Radioembolisation for colorectal carcinoma: results
M.S. Johnson (Indianapolis, IN/US)
 
2001.4 Lipiodol TACE for colorectal metastases: is there a role?
R. Lencioni (Miami, FL/US)
 
2001.5 Managing peri-procedural systemic therapy: whether to stop or continue in colorectal patients
G. Mauri (San Donato Milanese/IT)
 
2001.6 SIRFLOX trial: impact on treatment algorithm
A. Denys (Lausanne/CH)
 
2001.7 When should embolisation be considered for neuroendocrine tumours
T. de Baère (Villejuif/FR)
 
2001.8 Chemoembolisation and bland embolisation for neuroendocrine tumours
K. Ahrar (Houston, TX/US)
 
2001.9 TARE for neuroendocrine tumours
T.F. Jakobs (Munich/DE)
 
2001.10 When should embolisation be considered for cholangiocarcinoma
C.E. Ray, Jr. (Chicago, IL/US)
 
2001.11 Embolisation for cholangiocarcinoma: techniques and results
R. Lencioni (Miami, FL/US)
 
2001.12 Breast metastases to the liver
P.L. Pereira (Heilbronn/DE)
 
  Discussion  
     
 
  10:15-12:00  
  Parallel Session  
2002 Vanguard embolisations Main
  Moderators: M.D. Darcy (St. Louis, MO/US), V. Vidal (Marseille/FR) Auditorium
2002.1 Thermal ablation of vascular malformations
M.D. Darcy (St. Louis, MO/US)
 
2002.2 Gastric embolisation for weight loss
A. Arepally (Atlanta, GA/US)
 
2002.3 Embolisation of musculoskeletal pathology
Y. Okuno (Tokyo/JP)
 
2002.4 Embolisation of haemarthrosis
M.D. Darcy (St. Louis, MO/US)
 
2002.5 Embolisation for chronic haemorrhage from haemorrhoids
V. Vidal (Marseille/FR)
 
2002.6 Lymphangiographic approaches to lymphoceles
M. Itkin (Philadelphia, PA/US)
 
2002.7 The next phase in lymphatic interventions
M. Itkin (Philadelphia, PA/US)
2002.8 Thyroid embolisation for multi-goitre disease
O. Pellerin (Paris/FR)
 
  Discussion  


ICCIR 2012 was kindly sponsored by: